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lial cell line–derived neurotrophic factor (GDNF) and
hepatocyte growth factor (HGF) are multifunctional
signaling molecules in embryogenesis. HGF binds
to and activates Met receptor tyrosine kinase. The signaling
receptor complex for GDNF typically includes both GDNF
family receptor 
 
 
 
1 (GFR
 
 
 
1) and Ret receptor tyrosine kinase.
GDNF can also signal independently of Ret via GFR
 
 
 
1,
although the mechanism has remained unclear. We now
show that GDNF partially restores ureteric branching
 
morphogenesis in 
 
ret-
 
deﬁcient mice with severe renal hypo-
dysplasia. The mechanism of Ret-independent effect of
GDNF was therefore studied by the MDCK cell model. In
MDCK cells expressing GFR
 
 
 
1 but no Ret, GDNF stimu-
G
 
lates branching but not chemotactic migration, whereas
both branching and chemotaxis are promoted by GDNF in
the cells coexpressing Ret and GFR
 
 
 
1, mimicking HGF/
 
Met responses in wild-type MDCK cells. Indeed, GDNF
induces  Met phosphorylation in several 
 
ret
 
-deﬁcient/
GFR
 
 
 
1-positive and GFR
 
 
 
1/Ret-coexpressing cell lines.
However, GDNF does not immunoprecipite Met, making
a direct interaction between GDNF and Met highly improb-
able. Met activation is mediated by Src family kinases. The
GDNF-induced branching of MDCK cells requires Src acti-
vation, whereas the HGF-induced branching does not. Our
data show a mechanism for the GDNF-induced branching
morphogenesis in non-Ret signaling.
 
Introduction
 
Glial cell line–derived neurotrophic factor (GDNF)* regulates
ureteric branching in kidney morphogenesis, spermatogenesis,
and survival and differentiation of several neuronal populations
(Airaksinen et al., 1999; Sariola and Saarma, 1999; Baloh et
al., 2000; Meng et al., 2000). The receptor complex for
GDNF consists of Ret receptor tyrosine kinase and glyco-
sylphosphatidylinositol (GPI)-linked GDNF family receptor
 
 
 
1 (GFR
 
 
 
1) (Airaksinen et al., 1999). In the embryonic
kidney, GDNF is expressed by the metanephric mesenchyme
and is repressed by epithelial conversion of the mesenchymal
cells (Hellmich et al., 1996; Suvanto et al., 1996). GDNF-
releasing beads stimulate ureteric branching in cultured kidneys
and promote outgrowth of ectopic ureteric buds from the
nephric duct (Sainio et al., 1997). Neutralizing antibodies
to GDNF inhibit ureteric branching in kidney culture (Vega
et al., 1996).
 
ret
 
 is initially expressed along the nephric duct and the
ureteric bud (Pachnis et al., 1993). The receptor becomes
restricted to the growing tips of the bud as its branching
progresses. GFR
 
 
 
1 is expressed by both ureteric bud and
pretubular nephrogenic mesenchyme (Sainio et al., 1997).
 
Targeted disruption of 
 
ret
 
,
 
 gdnf
 
, or 
 
gfr
 
 
 
1
 
 genes results in
severe renal hypodysplasia or aplasia (Schuchardt et al.,
1994; Pichel et al., 1996; Sanchez et al., 1996; Cacalano et
al., 1998), confirming the critical role of GDNF/Ret signaling
in the ureteric branching.
Since GFR
 
 
 
1 lacks an intracellular domain, it was initially
considered as only a ligand-binding receptor for GDNF.
When complexed with two molecules of GDNF, a GFR
 
 
 
1
dimer induces dimerization of Ret, its recruitment to lipid
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rafts, and transphosphorylation of the tyrosine kinase do-
mains. Lipid rafts are cell membrane domains of sphingolipids
and cholesterol packed into moving platforms within the lipid
bilayer (Harder et al., 1998). The raft microdomains serve as
signaling compartments of the cell membrane, which concen-
trate raft-specific signaling molecules (Simons and Toomre,
2000). Ret is also activated in trans by GDNF via soluble or
matrix-bound GFR
 
 
 
1 (Paratcha et al., 2001). Moreover,
GDNF signaling via Ret is different in and outside the lipid
rafts (for review see Saarma, 2001).
GDNF can also signal via GFR
 
 
 
1 in a Ret-independent
manner (Poteryaev et al., 1999; Trupp et al., 1999). In pri-
mary sensory neurones isolated from 
 
ret
 
-deficient mice and
in a Ret-negative neuroblastoma cell line, GDNF activates
Src-type kinases (Poteryaev et al., 1999; Trupp et al., 1999).
There is also indirect evidence that GFR
 
 
 
1 might have
Ret-independent roles. First, GDNF binds to GFR
 
 
 
1 in the
absence of Ret (Jing et al., 1996). Second, 
 
ret
 
 and 
 
gfr
 
 
 
1
 
 ex-
pression patterns do not overlap in many tissues (Sainio et
al., 1997; Golden et al., 1999). However, nothing is known
about the mechanism and possible biological significance of
Ret-independent signaling via GFR
 
 
 
1
 
.
 
The MDCK dog kidney epithelial cells have been ex-
tensively used for studying the molecular mechanisms of
branching morphogenesis. Hepatocyte growth factor (HGF),
the ligand for Met receptor tyrosine kinase (Naldini et al.,
1991), induces scattering, chemotactic movements, and
tubule formation of MDCK cells (Stoker et al., 1987; Mon-
tesano et al., 1991). In the presence of soluble GFR
 
 
 
1, 
 
ret
 
-
transfected MDCK cells respond to GDNF like the wild-
type MDCK cells respond to HGF (Tang et al., 1998). In
vivo, HGF is required for the early development of liver,
limb muscles, and placenta, and it is involved in liver regen-
eration (Birchmeier and Gherardi, 1998). In organ culture,
HGF regulates ureteric bud branching and modulates epi-
thelial differentiation of metanephric mesenchymal cells
(Karp et al., 1994; Woolf et al., 1995; Sainio et al., 1997).
We now approached the role and mechanism of GFR
 
 
 
1 in
branching morphogenesis. These studies were prompted by our
observation that the ureteric branching morphogenesis of 
 
ret-
 
deficient mice was partially restored in organ culture when
GDNF was added to the culture medium. Therefore, we cre-
ated MDCK clones stably expressing GFR
 
 
 
1 alone or both
Ret and GFR
 
 
 
1. When stimulated by GDNF, the GFR
 
 
 
1-
expressing, 
 
ret
 
-deficient cells formed branching tubules in col-
lagen matrix, but they were completely incapable of responding
chemotactically to GDNF. In both GFR
 
 
 
1- and Ret/GFR
 
 
 
1-
expressing MDCK cell lines, GDNF induced Met phosphory-
lation, but the ligand did not directly interact with Met. Phar-
macological inhibition of Src-type kinases and transfection
experiments with dominant-negative (DN) or activated c-Src
showed that Src kinase activity is required for the GDNF-
induced activation of Met and tubulogenesis of MDCK cells.
 
Results
 
Exogenous GDNF partially restores the renal 
phenotype of ret-deficient mice
 
To analyze the possible role of Ret-independent, GFR
 
 
 
1-
mediated signaling in ureteric budding and branching dur-
ing nephrogenesis, we tested the ability of exogenous GDNF
to induce ureteric budding or sustain its branching in 
 
ret
 
-
deficient mice. Embryonic day (E)11 
 
ret
 
 
 
/
 
 
 
 urogenital blocks
including kidney rudiments were cultured for 4 d without or
with 50 ng/ml of GDNF (Fig. 1). As expected, the ureteric
buds of 
 
ret
 
 
 
/
 
 
 
 mice did not branch or branched rudimenta-
rily in the control media (Schuchardt et al., 1996). When
the culture medium was supplemented with GDNF, the
number of ureteric bud tips in the hypodysplastic kidneys of
Figure 1. Exogenous GDNF partially restores ureteric branching 
of ret-deficient kidneys. (A–D) Urogenital block explants including 
the Wolffian duct (wd), mesonephros (meso), and metanephros 
(meta) from E11 ret
 /  (A and B), ret
 /  (C), and ret
 /  (D) mouse 
embryos. The urogenital blocks from each embryo were separately 
cultured for 4 d, one side without GDNF (A, C and D) and the 
other one with 50 ng/ml of GDNF (B). The explants were fixed and 
immunolabeled as whole mounts with pan-cytokeratin antibodies. 
Bar, 200  m. (E) The number of ureteric branches of ret
 / , ret
 / , 
and ret
 /  kidneys with or without GDNF supplementation. The 
results represent the means   SEM. GDNF significantly increases 
ureteric branch number in ret
 /  explants compared with the control 
media (P   0.01).T
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ret
 
-deficient mice was increased but not to the level seen in
wild-type kidneys (Fig. 1, B and D). Exogenous GDNF in-
creased the number of ureteric bud tips in 
 
ret
 
 
 
/
 
 
 
, 
 
ret
 
 
 
/
 
 
 
, and
wild-type kidney explants (Fig. 1 E). However, with or with-
out exogenous GDNF the number of 
 
ret
 
 
 
/
 
 
 
 
 
urogenital ex-
plants completely lacking a ureteric bud remained the same
(Table I). Thus, Ret-independent signaling by GDNF has
an apparent role in the ureteric branching but may be less
significant in the primary bud formation.
 
GDNF induces branching of 
 
gfr
 
 
 
1
 
-transfected/
 
ret
 
-deficient MDCK cells
 
To study the possible mechanism and mode of action of
GDNF in GFR
 
 
 
1 and GFR
 
 
 
1/Ret signaling, MDCK cells
were transfected with expression vectors encoding the hu-
man 
 
ret
 
 and rat 
 
gfr
 
 
 
1
 
,
 
 
 
or 
 
gfr
 
 
 
1
 
 only with or without fused
GFP. Multiple clones expressing GFR
 
 
 
1 with or without
fused GFP and clones expressing Ret together with GFR
 
 
 
1
were identified by RT-PCR and Western blotting. The
clonal cell lines expressing GFR
 
 
 
1 with (N3) or without
GFP (N14) showed similar biological responses to GDNF
(Fig. 2 and unpublished data).
The possible endogenous 
 
ret
 
 expression by MDCK cells
was excluded by Northern blot and RT-PCR. The canine 
 
ret
 
cDNA was first cloned from adult dog testis. RT-PCR with
canine-specific 
 
ret
 
 primers and Northern blot showed that
 
ret
 
 is not expressed by MDCK cells. Furthermore, in
MDCK clones stably expressing 
 
gfr
 
 1, no induced ret ex-
pression was detected either by RT-PCR with the canine ret
primers or Western blotting (unpublished data).
Wild-type MDCK cells form fluid-filled cystic structures
in three-dimensional collagen gels. After HGF application,
the cells start forming branching tubules (Montesano et al.,
1991). When cultured in 100 ng/ml of GDNF, both
GFR 1- and Ret/GFR 1-MDCK cells formed branching
tubules, whereas wild-type (Fig. 2, A and B) and mock-
transfected cells did not (unpublished data). Persephin is the
ligand for GFR 4 (Enokido et al., 1998; Thompson et al.,
1998) and does not interact with GFR 1. It did not evoke
branching of GFR 1- and Ret/GFR 1-expressing MDCK
Table I. Ureteric bud branching in ret
 / , ret
 / , and ret
 /  urogenital explants with or without GDNF supplementation
a 
No budding  5 tips  5 tips
Control GDNF
b Control GDNF Control GDNF Number of explants
ret
 /  7 794 49 2 0
ret
 /  0 0 8 4 12 16 20
ret
 /  0 0 4 1 18 21 22
aThe results from the experiment shown in Fig. 1 E.
bUrgenital blocks from each embryo were seperated by microdissection and cultured for 4 d. One side served as a control, the other one was cultured with
50 ng/ml of GDNF.
Figure 2. GDNF induces branching 
of GFR 1-expressing MDCK cells in 
three-dimensional collagen gel. 
(A) Ret/GFR 1- and GFR 1-expressing 
MDCK cells were grown in collagen gel 
with GDNF (100 ng/ml), and wild-type 
MDCK cells were grown in collagen gel 
with HGF (50 ng/ml). BSA (100 ng/ml) 
was used as a negative control. Bar, 
100  m. (B) GDNF induces branching 
of GFR 1 and Ret/GFR 1 cells but not 
wild-type MDCK cells, which only 
respond to HGF. Persephin (PSPN; 
100 ng/ml) does not induce branching 
of any MDCK cell line tested. From the 
total number of cysts in the field, the 
percentage of cysts with long branches 
was calculated. Only the branches 
with the length of more than two cyst 
diameters were counted. (C) Dose 
dependency of the GDNF-induced 
branching of GFR 1- and Ret/GFR 1-
expressing MDCK cells. GDNF 
concentrations are marked per ml. 
Results are reported as fold of branching 
cysts over the noninduced control. 
Means   SEM of five to eight counted 
fields are shown. The results are 
representative of five (A and B) and 
three (C) independent experiments. 
(B and C) GDNF significantly increases branching in GFR 1- and Ret/GFR 1-expressing MDCK and HGF increases branching of 
wild-type MDCK (B) compared with the control media (P   0.001).T
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cells (Fig. 2 B). GDNF also induced branching tubulogene-
sis in wild-type MDCK cells transduced with an adenovirus
expressing GFR 1 (unpublished data).
The branching response of the cells expressing GFR 1
alone was highly sensitive to GDNF, since already 0.1 pg/ml
of GDNF evoked tubulogenesis. In contrast, the cells coex-
pressing Ret and GFR 1 started to branch only at 0.1 ng/ml
of GDNF (Fig. 2 C). Two GDNF preparations synthesized
by different methods by two different manufacturers were
tested (see Materials and methods), and both products
evoked branching of GFR 1-expressing MDCK cells al-
ready at low concentrations (0.1 pg/ml).
GFR 1-expressing cells do not respond 
chemotactically to GDNF in the absence of Ret
Guided migration of cells toward a chemoattractant is re-
ferred to as chemotaxis, whereas enhanced cellular motility
is called chemokinesis. Chemotaxis can be tested in the Boy-
den dual chamber assay by adding the test substance to the
lower chamber only, and chemokinesis can be tested by add-
ing the test substance to both upper and lower chambers.
Similar to the HGF-induced chemotaxis of the wild-
type MDCK cells (Stoker et al., 1987), the chemotactic
migration of ret-transfected MDCK cells is stimulated by
GDNF in the presence of soluble GFR 1 (Tang et al.,
1998). Accordingly, GDNF was chemotactic to MDCK
cells transfected with both ret and the GPI-anchored,
membrane-bound form of gfr 1. In contrast, the GFR 1-
expressing, ret-deficient MDCK cells did not show a che-
motactic response to GDNF under the same conditions
(Fig. 3 A).
GDNF was added to both chambers to test its possible
chemokinetic effects. The migration of Ret/GFR 1-express-
ing MDCK cells was reduced threefold compared with their
maximal chemotactic response. Similar reduction was ob-
served with HGF in wild-type MDCK cells. In contrast, the
migration of GFR 1-expressing cells was only marginally
reduced when GDNF was applied to both chambers (Fig.
3 A). Thus, GDNF is chemotactic to Ret/GFR 1-express-
ing cells and weakly chemokinetic but not chemotactic to
GFR 1-expressing, ret-deficient cells.
In another chemotaxis assay (Tang et al. 1998), ret/gfr 1-,
gfr 1-, and mock-transfected MDCK cells were seeded on
culture dishes coated by type I collagen. Agarose beads were
soaked in GDNF (10 ng/ l) or 1% BSA, a bead was placed
on top of collagen gel, and the cells were monitored for
3 d. Ret/GFR 1-expressing cells actively migrated toward
GDNF-releasing beads but not to those soaked in BSA (Fig.
3 B). gfr 1- and mock-transfected cells were not attracted by
the GDNF- or BSA-releasing beads (Fig. 3 B).
GDNF activates Met in both Ret-dependent 
and -independent signaling
Since both GDNF and HGF promoted branching of MDCK
cells and Met is the only receptor known to promote tubule
formation in these cells (Santos et al., 1993), we suggested
that GDNF may induce Met phosphorylation. In 15 min,
GDNF indeed evoked Met phosphorylation in GFR 1- and
Ret/GFR 1-expressing MDCK cells but not in wild-type
MDCK cells. Saturation was reached at 0.1 pg/ml (Fig. 4, A
Figure 3. GFR 1-expressing, ret-deficient MDCK cells do 
not show a chemotactic response to GDNF. (A) In the Boyden 
chamber chemotaxis assay, the mock-transfected, GFR 1, and 
Ret/GFR 1 cells were exposed to GDNF (10 and 100 ng/ml), 
and wild-type MDCK were exposed to HGF (10 and 100 ng/ml). 
The number of cells was counted as described in Materials and 
methods.  / , 100 ng/ml of GDNF or 50 ng/ml of HGF were 
added to both chambers to assay chemokinesis. The results 
represent the means   SEM (n   3). ***P   0.001. (B) Chemo-
attraction assay on collagen matrix. Only Ret/GFR 1-expressing 
cells migrate toward GDNF-soaked beads. BSA-soaked agarose 
beads were used as negative control. Beads are marked by a white 
circle. Note that mock, GFR 1-expressing cells with GDNF-soaked 
beads and Ret/GFR 1-expressing cells with BSA-soaked bead 
form clusters of adherent cells (marked with arrowhead) after 3 d, 
whereas the Ret/GFR 1-expressing cells migrating toward the 
GDNF bead are scattered.T
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and B). The same concentration of GDNF also induced rapid
Met phosphorylation in human neuroblastoma SHEP cells
(unpublished data), which express GFR 1 but no Ret (Po-
teryaev et al., 1999). GDNF activated Met in GFR 1- and
Ret/GFR 1-expressing MDCK cells already in 15 min (Fig.
4, A and B), and the activation lasted at least 2 h (unpub-
lished data). In the mock-transfected MDCK cells, only HGF
phosphorylated Met (Fig. 4 C). In Ret/GFR 1-expressing
MDCK cells, Ret was phosphorylated already at 0.1 pg/ml of
GDNF, and saturation was reached at 10 ng/ml (Fig. 4 D).
In a series of cross-linking immunoprecipitation exper-
iments, we tested whether GDNF activates Met directly
or indirectly. Binding of 
125I-GDNF to GFR 1-expressing
MDCK, SHEP, or COS7 cells and NIH 3T3 cells transiently
transfected with gfr 1 was followed by chemical cross-linking
and immunoprecipitation with anti-Met antibodies. No
high molecular weight complexes were revealed, and in total
lysates the bands represent different complexes of 
125I-GDNF
(monomers or dimers) and the dimers of GFR 1 (Fig. 5).
Different cross-linkers, such as EDC with sulfo-NHS, BS
3,
DSS, and DSP, were tested, and the result remained the same
(Fig. 5 and unpublished data). A direct association of the
GDNF receptor complex and Met was not detected in Ret/
GFR 1-expressing MDCK cells either (unpublished data).
Cross-linking of 
125I-HGF in COS7 cells followed by im-
munoprecipitation with anti-Met antibodies was used as a
positive control. It resulted in  200-, 250-, and 340-kD
Figure 4. GDNF induces phosphorylation of Met. (A and B) Dose-dependent phosphorylation of Met by GDNF in GFR 1- and Ret/GFR 1-
expressing MDCK cells. Met was activated in 15 min after GDNF application. The bottom panels show the reprobing of the same filter 
with anti-Met antibodies. The numbers below the lanes indicate the fold of induction of Met tyrosine kinase. (C) Phosphorylation of Met in 
mock-transfected MDCK cells. Concentrations of GDNF and HGF are given in ng/ml. 30  g of total proteins were incubated with 10  l of 
immobilized phosphotyrosine mAbs, and immunocomplexes were washed and analyzed as described in Materials and methods. (D) Dose-
dependent activation of Ret by GDNF in Ret/GFR 1-expressing MDCK cells. The bottom panel shows the reprobing of the same filter with 
anti-Ret antibodies. The numbers below the lanes indicate the fold of induction of Ret tyrosine kinase. IP, immunoprecipitation; WB, Western 
blotting; P-tyr, phosphotyrosine. The results are representative of three independent experiments.
Figure 5. GFR 1 does not complex with Met. Binding of 
125I-GDNF 
to COS7 cells transfected with gfr 1 and 
125I-HGF to wild-type COS7 
followed by cross-linking with EDC together with sulfo-NHS. Immuno-
precipitates with anti-Met antibodies (IP:Met) were analyzed by SDS-
PAGE under reducing conditions. In total lysates (TL), different com-
plexes of 
125I-GDNF (monomers or dimers) and the dimers of GFR 1 
are marked with a square bracket. 
125I-HGF   subunit and proHGF are 
marked by arrows. 
125I-HGF–Met complexes are indicated by arrow-
heads. The results are representative of five independent experiments.T
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complexes under reducing conditions (Fig. 5). They represent
different combinations of the Met  -subunit (140 kD), Met-
   heterodimer (190 kD), and HGF complexes (60–90 kD).
GDNF-induced phosphorylation of Met is mediated 
by Src family kinases
Already 0.1 pg/ml of GDNF saturated Src phosphorylation
at Tyr418, demonstrating Src activation in both GFR 1-
and Ret/GFR 1-expressing MDCK cells (Fig. 6 A). 1  M
concentration of the Src-type kinase inhibitor PP2 inhibited
GDNF-induced Met activation in both GFR 1- and Ret/
GFR 1-expressing MDCK cells but not in the HGF-
induced Met phosphorylation in these cells (unpublished
data). Accordingly, PP2 strongly reduced the GDNF-depen-
dent phosphorylation of Met in SHEP cells endogenously ex-
pressing GFR 1 but not Ret (Fig. 6 B) and did not affect
HGF-induced Met phosphorylation (Fig. 6 B).
We used adenoviruses to introduce DN c-Src or activated
c-Src to GFR 1- and Ret/GFR 1-expressing and wild-type
MDCK cells. Both constructs contained gfp under a separate
promoter, which enabled us to monitor the infection effi-
ciency. It was close to 100% in all experiments. Adenovi-
ruses with gfp alone were used as a control. In accordance
with the results with PP2, DN c-Src efficiently blocked Src
phosphorylation and Met activation induced by GDNF but
not that induced by HGF (Fig. 7 A). Expression of activated
c-Src resulted in GDNF-independent phosphorylation of
Met, which could not be further increased by GDNF. In
contrast, HGF enhanced Met phosphorylation in wild-type
MDCK-expressing activated c-Src (Fig. 7 A).
GFR 1-, Ret/GFR 1-, and wild-type MDCK cells trans-
duced with adenoviruses expressing DN c-Src, activated c-Src,
or GFP were grown in collagen gel to analyze branching re-
sponses. DN c-Src suppressed GDNF- but not HGF-induced
Figure 6. GDNF-induced activation of Met requires Src kinase. (A) Dose-dependent Src kinase activation by GDNF in GFR 1- and Ret/GFR 1-
expressing MDCK cells. The activation of Src-type kinases was observed after 15 min. The concentrations of GDNF are marked. The bottom 
panel shows mock-transfected MDCK cells induced with 50 ng/ml of HGF and 100 ng/ml of GDNF. The numbers below the lane indicate the 
fold of increase in phosphorylation of Tyr418 of Src. The bottom panels show the reprobing of the same filter with anti-Src antibodies. The results 
are representative of three independent experiments. (B) SHEP cells were grown with GDNF (10 ng/ml and 5 pg/ml) or HGF (10 ng/ml) in the 
presence of PP2 (1 and 10  M). To exclude a possible cytotoxic effect of the solvent, DMSO was added to the controls. The bottom panel 
shows the reprobing of the same filter with anti-Met antibodies. Bottom picture demonstrates wild-type MDCK cells induced with 50 ng/ml 
of HGF and 100 ng/ml of GDNF. Numbers below the lane indicate the fold of induction of Met tyrosine kinase. The results are representative 
of three independent experiments.T
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branching tubulogenesis (Fig. 7 B). Activated c-Src evoked
branching in a ligand-independent manner in all tested MDCK
lines. In the presence of activated c-Src, HGF but not GDNF
further increased the number of branching cysts (Fig. 7 B).
Discussion
We demonstrate the first Ret-independent morphological re-
sponses to GDNF. First, it partially restores the ureteric
branching of ret-deficient hypodysplastic kidneys when applied
Figure 7. GDNF-induced branching tubulogenesis of GFR 1- and Ret/GFR 1-expressing cells require c-Src kinase. GFR 1- and Ret/GFR 1-
expressing and wild-type MDCK cells were infected with adenovirus constructs containing DN c-Src, activated c-Src, or adeno-GFP. 
(A) GDNF-induced Met activation depends on c-Src kinase. 1 d after the adenovirus infection, GFR 1- and Ret/GFR 1-expressing MDCK 
cells were induced with GDNF (50 ng/ml) and wild-type MDCK also with HGF (50 ng/ml). Aliquots of total cell lysates were immunoblotted 
with anti-Y
418 Src, and the rest of lysates were immunoprecipitated with anti-Met antibodies and immunoblotted using antiphosphotyrosine 
antibodies. The results are representative of two independent experiments. (B) After infection cells were put in collagen gel culture, GFR 1- 
and Ret/GFR 1-expressing cells were grown with or without GDNF (50 ng/ml), wild-type MDCK with or without HGF (50 ng/ml). After 3 d, 
the cells were fixed and counted as described in Materials and methods. The results are representative of three independent experiments.T
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to the culture medium. Second, GDNF induces branching but
not chemotactic migration of MDCK cells expressing GFR 1
but not Ret. Because Met is the only receptor to promote
branching of wild-type MDCK cells, we tested whether
GDNF activates Met in non-Ret signaling. Indeed, in MDCK
cells and several other cell types, GDNF binding to GFR 1
activates Met indirectly via Src family kinases. Src activation is
essential for both Met activation and branching morphogene-
sis. These data underline the role of GFR 1 in the ureteric
branching morphogenesis and provide biochemical and bio-
logical evidence for a novel signaling mechanism for GDNF.
The development of the mammalian permanent kidney or
metanephros requires reciprocal inductive interactions between
the metanephric mesenchyme and the ureteric bud (Kuure et
al., 2000). GDNF is an essential mesenchymal signal for ure-
teric budding and branching (Sariola and Saarma, 1999), and it
has been assumed to signal during kidney morphogenesis via
the GFR 1 and Ret complex, because GDNF-soaked beads
fail to induce ectopic buds from Wolffian ducts of ret-deficient
mice (Sainio et al., 1997) and wild-type metanephric mesen-
chymes cocultured with ret-deficient ureteric buds do not re-
store branching (Schuchardt et al., 1996). It is notable that the
renal phenotype of the mice lacking Ret is variable ranging
from total aplasia to hypodysplasia. The metanephric develop-
ment is initiated in 61% of ret-deficient embryos (Schuchardt
et al., 1996). We now managed to partially restore branching of
ret-deficient hypodysplastic kidney rudiments by exogenous
supplementation of GDNF but failed to decrease with GDNF
the number of kidney explants with complete renal aplasia. The
data suggest that Ret-independent signaling via GFR 1 rather
sustains the ureteric branching than initiates bud formation
from the Wolffian duct. However, the proper orientation of
the tips of the ureteric buds within the nephrogenic mesechyme
might be critically controlled by Ret activity, since it is only in
the presence of Ret that the GFR 1-expressing MDCK cells
react chemotactically to GDNF.
The molecular mechanisms of chemokinesis, chemotaxis,
and tubulogenesis are at least partially different. In HGF sig-
naling, Grb2 and PLC  are crucial for tubulogenesis but not
important for cell scattering (Royal et al., 1997; Gual et al.,
2000). A downstream target of PI3-K, p70, is required for
MDCK cell motility and dissociation but not for tubulogen-
esis (Royal et al., 1997). In contrast to the GDNF-induced
Ret activation, the GFR 1-mediated Met activation pro-
motes tubulogenesis but only weak chemokinetic motility of
MDCK cells. In the presence of Ret, Met activation by
GDNF probably involves different downstream adaptors
than in GFR 1-mediated, non-Ret signaling and therefore
evokes different cell responses.
GFR 1, a GPI-linked receptor, does not have an intracellu-
lar domain. In the absence of Ret, GFR 1 apparently employs
other transmembrane molecule(s) for signal transduction. The
similarity of the GDNF- and HGF-induced branching re-
sponses of MDCK cells prompted us to study the possible in-
terplay of GDNF and Met. Indeed, GDNF evokes Met phos-
phorylation in both GFR 1- and Ret/GFR 1-expressing cells
but not in wild-type MDCK cells. Met activation by GDNF is
not restricted to a particular cell line or cell type, since it takes
place in SHEP cells endogenously expressing GFR 1, in gfr 1-
transfected COS7 cells, and NIH 3T3 fibroblasts. However,
the cross-linking immunoprecipitation experiments using sev-
eral different chemical cross-linkers and several cell lines failed
to detect any GDNF complexes with Met, making a direct
binding of GFR 1 and Met highly improbable.
Src-type kinases were putative candidates to mediate the
GDNF signaling from GFR 1 to Met because they are asso-
ciated with the lipid rafts like GFR 1 (Harder et al., 1998),
they are activated in Ret-independent signaling by GDNF
(Poteryaev et al., 1999; Trupp et al., 1999), c-Src kinase is as-
sociated with Met after receptor activation (Rahimi et al.,
1998), and integrin-mediated activation of Ron receptor ty-
rosine kinase, homologous to Met, requires c-Src (Danilko-
vitch-Miagkova et al., 2000). Indeed, inhibition of Src-type
kinases by PP2 prevents phosphorylation of Met by GDNF
but not by HGF. Moreover, expression of DN c-Src blocks
GDNF-induced Met phosphorylation and branching tubu-
logenesis in GFR 1- and Ret/GFR 1-expressing MDCK
cells, but it does not affect HGF-induced branching in wild-
type MDCK cells. These findings are in agreement with the
results reported by Rahimi et al. (1998). They demonstrated
that DN c-Src does not alter the phosphorylation level of
Met in a mouse mammary carcinoma cell line SP1. Thus, Src
family kinases are upstream to Met in the GDNF-induced
activation but downstream to Met in the HGF-induced acti-
vation. In MDCK cells, c-Src is apparently involved in non-
Ret signaling, but the role of other Src kinases remains open.
Already low concentrations of GDNF induce phosphory-
lation of Met in both GFR 1- and Ret/GFR 1-expressing
MDCK cells. Intriguingly, Met is saturated by GDNF at 4
fM (0.1 pg/ml), whereas HGF saturates Met at 0.5 nM
(Villa-Moruzzi et al., 1993). The phenomenon of femtomo-
lar concentrations causing activation of a signaling pathway
and biological response is not unique. Femtomolar levels of
GABA neurotransmitter stimulate migration of a subpopu-
lation of cortical neurons (Behar et al., 1996, 1998). Simi-
larly, the delta opioid peptide [D-Ala
2,D-Leu
5]enkephalin
promotes PC12 cell survival via the MEK-ERK pathway at
femtomolar concentration (Hayashi et al., 2002).
Different doses of GDNF and the receptor context define
the cellular responses to the ligand. Low doses of GDNF in-
duce branching but not chemotaxis of GFR 1-expressing,
ret-deficient MDCK cells. When Ret is present, GDNF in-
duces both branching and chemotaxis but only at a high
concentration. Thus, RET obviously negatively controls
branching at low doses of GDNF. The GFR 1–Ret com-
plex may be less stable than the GFR 1 complex, which
may increase the GDNF binding sites in the absence of Ret
and initiate the branching response at low GDNF doses. It is
also possible that the GFR 1–Ret complex is internalized
without ligand faster than the GFR 1 complex. On the
other hand, it is apparent that Ret is essential for the chemo-
tactic response to GDNF.
Kidney development is normally initiated in Met- and
HGF-deficient mice (Birchmeier and Gherardi, 1998). These
animals die around E13–15 due to severe malformations in
placental and liver morphogenesis (Schmidt et al., 1995). In
kidney culture, the antibodies neutralizing HGF disrupt kid-
ney development suggesting a role of HGF/Met signaling in
kidney morphogenesis (Woolf et al., 1995). On the other
hand, GDNF/Ret/GFR 1 signaling plays a crucial role inT
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kidney differentiation both in vivo and in vitro (Schuchardt
et al., 1994; Pichel et al., 1996; Sanchez et al., 1996; Caca-
lano et al., 1998). The in vivo contribution of GDNF/Met
signaling in kidney morphogenesis should be further eluci-
dated by Ret/Met- or conditional Met-deficient mice.
Both met and ret are protooncogenes. Met is up-regulated
in several different cancer forms (Giordano et al., 2000), and
hgf and met are frequently overexpressed in breast carcinomas
(Tuck et al., 1996; Ghoussoub et al., 1998). Activated Ret
upregulates  met in normal human thyrocytes (Ivan et al.,
1997). Mutations in met have been found in the familial pap-
illary renal cancer and in few cases of sporadic papillary renal
cancer (Schmidt et al., 1997; Zhuang et al., 1998). Onco-
genic ret mutations cause multiple endocrine neoplasia type
2A and 2B syndromes, familial medullary thyroid cancer,
and pheochromocytomas (Pasini et al., 1996; Edery et al.,
1997). c-Src, which is activated after Met and Ret phosphor-
ylation, is highly expressed in human breast cancer (Otten-
hoff-Kalff et al., 1992) and is activated in SP1 carcinoma cells
(Rahimi et al., 1996, 1998). The sustained activation of c-Src
stimulates expression of HGF in carcinoma cells, which may
lead to invasiveness and metastasis (Hung and Elliott, 2001).
Different cell lines expressing oncogenic forms of Ret possess
high Src kinase activity levels (Melillo et al., 1999). The in-
terplay between Met, Ret, and Src kinases might also be cru-
cial in carcinogenesis, since GDNF induces Met phosphory-
lation in Neuro-2A neuroblastoma cells.
During recent years, evidence for cross-talk between heter-
ologous receptor tyrosine kinases and signaling pathways
has rapidly emerged. A neuromodulator, adenosine, acting
through the A2A receptors activates Trk neurotrophin recep-
tors in the absence of their ligands (Lee and Chao, 2001).
Binding of nerve growth factor to TrkA promotes phosphor-
ylation of Ret in a GDNF-independent manner (Tsui-Pier-
chala et al., 2002). Met is also activated by factors other than
HGF. The Listeria surface protein InIB binds to and phos-
phorylates Met (Shen et al., 2000), and epidermal growth
factor receptor activates Met in transformed cells (Bergstrom
et al., 2000; Jo et al., 2000). Src family kinases are one of
the  mediators between receptor complexes (Danilkovitch-
Miagkova et al., 2000; Lee and Chao, 2001). Obviously, a
horizontal activation mechanism of a receptor tyrosine ki-
nase by heterologous ligand/receptor systems may be more
common than assumed. The horizontal activation of Met by
GDNF via Src demonstrates a synergy of two signaling sys-
tems, which should be taken in consideration when the bio-
logical and pathological effects of Met, GFR 1, or Ret are
studied. It remains to be resolved whether other GDNF fam-
ily ligands using different GFR s for ligand binding can ac-
tivate Met or other receptor tyrosine kinases.
Materials and methods
Cell culture and transfections
Early passage MDCK cells were provided by Dr. E. Lehtonen (Haartman Insti-
tute, University of Helsinki). Cells were cultured in MEM with 10% FCS. Hu-
man SHEP neuroblastoma cells and Neuro-2A were cultured in RPMI 1640
with 10% FCS. NIH 3T3 and COS7 cells were cultured in DME with 10%
FCS and transiently transfected with pcDNA3-GFR 1/GFP using FuGene 6
TM
reagent (Roche). For creation of stable lines, MDCK cells were transfected in
equal portions with pcDNA3-Ret, pcDNA3-GFR 1, and pcDNA3-GFR 1/
GFP using FuGene 6
TM reagent and selected with 400  g/ml G418 (GIBCO
BRL, Life Technologies). After 2 wk of selection, multiple clones were col-
lected and the expression of ret and/or gfr 1 was verified by RT-PCR and
Western blotting. Ret/GFR 1 (N7 and N17), GFR 1 (N14), and GFR 1-GFP
(N2 and N3) clones which showed high level of exogenous protein expres-
sion according to the Western blot were used for further analyses.
GFP-GFR 1 fusion expression plasmid construction
The entire GFP coding sequence except first methionine was amplified by
PCR with primers: 5 -aattgctagcgtgagcaagggcgaggagc-3 ; 5 -aattgctagct-
tacttgtacagctcgtcc-3 . The primers contained NheI restriction sites flanking
the GFP sequence. The GFR 1 full coding sequence cloned into pcDNA3
expression vector was subjected to “inverse PCR.” The “sense” GFR 1
primer with NheI (5 -aattgctagcgaccgtctggactgtgtgaaag-3 ) was designed to
anneal to the beginning of mature GFR 1 sequence, whereas the “anti-
sense” primer with NheI (5 -tatagctagctccaccactcacctcggcgg-3 ) annealed
to the end of signal leader peptide of GFR 1 precursor. The resulting PCR
products were digested with NheI and ligated. The expression construct
therefore is the NH2-terminal fusion of mature GFR 1 to GFP preceded by
in-frame signal peptide of GFR 1 with starting methionine, which targets
the fusion to the extracellular protein pathway. The membrane localization
of the fusion was checked by confocal microscopy in transiently trans-
fected SHEP and Neuro-2a cells (unpublished data).
Construction of Src mutants recombinant adenoviruses
Wild-type and DN c-Src cDNA were a gift from Dr. Joan Brugge (Harvard
Medical School, Boston, MA). Activated c-Src was obtained by introducing
a tyrosine to phenylalanine mutation at position 527 using a mutated PCR
primer: 5 -GCTCTAGACTATAGGTTCTCCCCGGGCTGGAACTGTGGCT-
AGTGGAC-3 . The adenoviruses were generated using the pAdEasy re-
combination system as described in He et al. (1998). Briefly, the Src mu-
tants were cloned in the shuttle vector pAdTrack, recombined in bacteria
with the adenoviral vector pAdEasy, linearized, transfected, and amplified
in 293A cells. The virus particles were purified on CsCl gradients, dia-
lyzed, and titered in 293A cells. For the infection of GFR 1- and Ret/
GFR 1-expressing and wild-type MDCK cells we used 5 pfu/cell of
Adeno-DN c-Src, Adeno-activated c-Src and Adeno-GFP diluted in serum-
free DME with 15 mM Hepes, pH 7.4.
Cloning of ret cDNA from dog testes
Total RNA was isolated with Trizol reagent (GIBCO BRL, Life Technolo-
gies) from autopsy samples of adult dog testes (Veterinary Hospital, Uni-
versity of Helsinki). Reverse transcription reaction was performed using Su-
perscript II RT (GIBCO BRL, Life Technologies). PCR was run for 40 cycles
with primers for human c-ret 5 -AGACGTGGTACCTGCATCAGG-3  and
5 -CGTTGAAGTGGAGCAAGAGG-3 . The PCR product was cloned into
pGEM-T vector (Promega) and sequenced (sequence data available from
GenBank/EMBL/DDBJ under accession no. AF364316).
Primers from nucleotides 29–49 and 225–244 of GenBank/EMBL/DDBJ
sequence no. AF364316 were used in RT-PCR analysis for canine ret ex-
pression. For Northern blot, 30  g of total RNA per lane was separated in
1.2% formaldehyde-agarose gel and transferred by capillary blotting onto
Hybond-N membrane (Amersham Biosciences) according to the manufac-
turer’s instructions. Blot was hybridized with [
32P]dCTP-labeled canine ret
probe (sequence data available from GenBank/EMBL/DDBJ under accession
no. AF364316) and washed in stringent conditions (Sambrook et al., 1989).
Western blotting and immunoprecipitation
To analyze Src activation, subconfluent GFR 1- and Ret/GFR 1-express-
ing MDCK cell cultures were starved for 24 h before induction into serum-
free MEM. After a 10-min incubation at 37 C with 50 ng/ml GDNF (Ceph-
alon Inc. or R&D Systems) or 50 ng/ml HGF (Sigma-Aldrich), cells were
lysed in lysis buffer supplemented with 1 mM Na-orthovanadate and ana-
lyzed on Western blots as described (Lindahl et al., 2001). Blots were
probed with the indicated antibodies and developed with ECL reagents
(Amersham Biosciences). The following antibodies were used: anti-Y
418 Src
and anti-Src (BioSource International). Phospho-specific antibody to
Tyr418 detects activated form of p60Src (Abram and Courtneidge, 2000).
To detect Met activation, GFR 1- and Ret/GFR 1-expressing MDCK,
mock-transfected MDCK, or SHEP cells were starved overnight in MEM or
RPMI 1640 with 1% FCS accordingly and in serum-free medium for 2 h
prior the induction. After a 15-min incubation at 37 C with indicated con-
centrations of GDNF or 50 ng/ml, HGF cells were lysed as described.
Cleared cell lysates were incubated with anti-Met antibodies (Santa Cruz
Biotechnologies, Inc.) overnight at 4 C. Immunoprecipitates were col-
lected with protein A–Sepharose (Amersham Biosciences), washed, sepa-
rated by SDS-PAGE, and transferred to Hybond-ECL membranes. Mem-T
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branes were immunoblotted with antiphosphotyrosine antibodies (Upstate
Group Inc.) or anti-Met. The same procedure was repeated to detect Ret
phosphorylation in Ret/GFR 1-expressing MDCK, only incubation time
with GDNF was changed for 2 h. Anti-Ret antibodies (Santa Cruz Biotech-
nologies, Inc.) were used for immunoprecipitation and immunoblotting.
Alternatively, 30  g of total proteins were incubated overnight at 4 C
with 10  l immobilized phosphotyrosine mAbs (Cell Signaling, NEB). Im-
munocomplexes were washed and analyzed as described. Densitometry
and quantifications were done using TINA 2.0 program.
For the inhibition of Met and Src activation, SHEP or GFR 1- and Ret/
GFR 1-expressing MDCK cells were starved as described above. 1 or 10
 M of PP2 (Calbiochem) was added 30 min before induction by GDNF or
HGF. The solvent DMSO was added to the positive controls together with
GDNF or HGF.
125I-labeled GDNF and HGF binding, chemical cross-linking
GDNF and HGF were enzymatically iodinated with [
125I]NaI (Amersham
Biosciences) with lactoperoxidase to a specific activity of 100,000 cpm/ng
as described (Lindahl et al., 2001). COS7 cells were transfected with
pcDNA3-GFR 1/GFP 2 d prior the assay. 2 nM of 
125I-GDNF or 1 nM of
125I-HGF were allowed to bind to cell monolayers for 1–2 h on ice in bind-
ing buffer (DME/15 mM Hepes, pH 7.5; 0.2% BSA), washed, and chemi-
cally cross-linked for 30 min at RT using BS
3, DSS, DSP, or EDC with sulfo-
NHS (Pierce Chemical Co.). The nonspecific binding of GDNF was esti-
mated by the amount of 
125I-GDNF binding to cells in the presence of 300
nM unlabeled GDNF. Cells were washed, lysed, and immunoprecipitated
with anti-Met antibodies as described. Gels were dried and analyzed by
phosphorimaging in a BAS Reader 1800 (Fuji).
Cell migration and chemotaxis assays
5   10
4 GFR 1- and Ret/GFR 1-expressing and mock transfected MDCK
cells were suspended in 300  l of MEM with 10% FCS and seeded into 24-
well cell culture inserts with the filters (Boyden chambers) (pore size 8  m;
Falcon). The assay was done as described (Tang et al., 1998). Briefly,
GDNF or HGF was added to the top or both the bottom and top chambers
at the marked concentrations. After a 48-h incubation, nonmigrated cells
on the upper surface of the filters were scrapped. Membranes with the
cells on the bottom surface were washed with PBS, fixed by 3% glutaralde-
hyde in PBS, stained with May-Grünwald Giemsa (MGG) solution, dehy-
drated, and mounted on the slides. Cells in eight fields of each membrane
were counted at the magnification 100  under the light microscope. The
average and standard error of the mean were calculated. Significance of
the differences was estimated by t test.
3.5-cm dishes were coated with collagen I solution, and 20,000 cells
were seeded on top of it. GDNF-soaked agarose beads, prepared as de-
scribed (Sainio et al., 1997), were put on the gel before it solidified. Cells
around the beads were photographed daily.
Branching tubule formation assay in collagen gel
Trypsinised cells were mixed 1:3 with collagen type I solution and plated.
MEM with 10% FCS was overlaid on the gels with or without GDNF
(Cephalon Inc. or R&D Systems) or 50 ng/ml HGF. Cells in collagen were
cultured for 3 d; GDNF-containing medium was changed daily. For quan-
tification, cells were cultured for 3 d, fixed by 3% glutaraldehyde in PBS,
and counted under a light microscope.
To avoid the effect of possible contamination of GDNF preparation,
GDNF from two different sources were tested. One GDNF product was ex-
pressed in baculovirus-infected insect cells (Cephalon Inc.), and the an-
other one was expressed in mouse myeloma cell line NSO (R&D Systems).
Kidney cultures
Kidney rudiments were isolated from NMRI mouse embryos at E11 (the vag-
inal plug day was designated as E0) and cultured on Nuclepore filters (pore
size 1  m) on top of metal grids. The embryos from the breeding of ret
 / 
mice were genotyped by PCR. The medium (DME with 10% FCS) was sup-
plemented in some dishes with 50 ng/ml GDNF (R&D Systems). After 4 d of
culture, the kidney rudiments were fixed in ice-cold methanol and immuno-
histochemically stained as whole-mounts as described (Sainio et al., 1997).
Anti–pan-cytokeratin antibodies (Sigma-Aldrich) were used as primary, and
the secondary antibodies were TRITC-anti–mouse IgG (Sigma-Aldrich).
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